cupric sulfide has been researched along with Hemolysis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Liao, G; Qin, Z; Qiu, M; Xiong, Z; Xu, Z; Yang, S; Zhang, Q | 1 |
Hirosawa, N; Kumar, DS; Maekawa, T; Mohamed, MS; Mohanan, PV; Poulose, AC; Radhakrishnan, N; Sakamoto, Y; Suzuki, Y; Veeranarayanan, S; Yudasaka, M; Zhang, M | 1 |
2 other study(ies) available for cupric sulfide and Hemolysis
Article | Year |
---|---|
Development of copper vacancy defects in a silver-doped CuS nanoplatform for high-efficiency photothermal-chemodynamic synergistic antitumor therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Copper; Drug Development; Female; Hemolysis; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanoparticles; Photothermal Therapy | 2021 |
Characterizing the biocompatibility and tumor-imaging capability of Cuâ‚‚S nanocrystals in vivo.
Topics: Animals; Biocompatible Materials; Cell Proliferation; Copper; Female; Hemolysis; Humans; Hydrogen-Ion Concentration; Lipid Peroxidation; Liver; Luminescent Measurements; Male; MCF-7 Cells; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Oxidative Stress; Polyethylene Glycols; Spleen; Transplantation, Heterologous | 2015 |